دورية أكاديمية
أعرض في EDS

Design, synthesis and evaluation of tryptophan analogues as tool compounds to study IDO1 activity.

التفاصيل البيبلوغرافية
العنوان: Design, synthesis and evaluation of tryptophan analogues as tool compounds to study IDO1 activity.
المؤلفون: Cundy NJ; School of Chemistry, University of Birmingham Edgbaston Birmingham B15 2TT UK r.s.grainger@bham.ac.uk., Hare RK; Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester Manchester M13 9PL UK., Tang T; Celentyx Ltd, Birmingham Research Park 97 Vincent Drive Birmingham B15 2SQ UK., Leach AG; Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester Manchester M13 9PL UK sam.butterworth@manchester.ac.uk., Jowitt TA; Wellcome Trust Centre for Cell Matrix Research, Faculty of Biology, Medicine and Health, University of Manchester Manchester M13 9PL UK., Qureshi O; Celentyx Ltd, Birmingham Research Park 97 Vincent Drive Birmingham B15 2SQ UK., Gordon J; Celentyx Ltd, Birmingham Research Park 97 Vincent Drive Birmingham B15 2SQ UK., Barnes NM; Celentyx Ltd, Birmingham Research Park 97 Vincent Drive Birmingham B15 2SQ UK.; Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham Edgbaston Birmingham B15 2TT UK., Brady CA; Celentyx Ltd, Birmingham Research Park 97 Vincent Drive Birmingham B15 2SQ UK.; Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham Edgbaston Birmingham B15 2TT UK., Raven EL; School of Chemistry, University of Bristol Cantock's Close Bristol BS8 1TS UK., Grainger RS; School of Chemistry, University of Birmingham Edgbaston Birmingham B15 2TT UK r.s.grainger@bham.ac.uk., Butterworth S; Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester Manchester M13 9PL UK sam.butterworth@manchester.ac.uk.
المصدر: RSC chemical biology [RSC Chem Biol] 2021 Sep 13; Vol. 2 (6), pp. 1651-1660. Date of Electronic Publication: 2021 Sep 13 (Print Publication: 2021).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101768727 Publication Model: eCollection Cited Medium: Internet ISSN: 2633-0679 (Electronic) Linking ISSN: 26330679 NLM ISO Abbreviation: RSC Chem Biol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Cambridge : Royal Society of Chemistry, [2020]-
مستخلص: The metabolism of l-tryptophan to N -formyl-l-kynurenine by indoleamine-2,3-dioxygenase 1 (IDO1) is thought to play a critical role in tumour-mediated immune suppression. Whilst there has been significant progress in elucidating the overall enzymatic mechanism of IDO1 and related enzymes, key aspects of the catalytic cycle remain poorly understood. Here we report the design, synthesis and biological evaluation of a series of tryptophan analogues which have the potential to intercept putative intermediates in the metabolism of 1 by IDO1. Functionally-relevant binding to IDO1 was demonstrated through enzymatic inhibition, however no IDO1-mediated metabolism of these compounds was observed. Subsequent T m -shift analysis shows the most active compound, 17, exhibits a distinct profile from known competitive IDO1 inhibitors, with docking studies supporting the hypothesis that 17 may bind at the recently-discovered S i site. These findings provide a start-point for development of further mechanistic probes and more potent tryptophan-based IDO1 inhibitors.
Competing Interests: NJC was a PhD student sponsored by Celentyx Ltd. TT, OQ, CAB are employees of Celentyx Ltd with share options in the company. JG and NMB are Directors of Celentyx Ltd with shareholdings in the company. There are no other conflicts to declare.
(This journal is © The Royal Society of Chemistry.)
References: Front Immunol. 2018 Jan 31;9:151. (PMID: 29445380)
Gene. 2007 Jul 1;396(1):203-13. (PMID: 17499941)
J Biol Chem. 1957 Dec;229(2):889-96. (PMID: 13502350)
Sci Rep. 2016 Oct 20;6:35169. (PMID: 27762317)
J Am Chem Soc. 2009 Sep 16;131(36):12866-7. (PMID: 19737010)
Biochemistry. 2011 Apr 12;50(14):2717-24. (PMID: 21361337)
Front Immunol. 2014 Aug 11;5:384. (PMID: 25157255)
Biochemistry. 2010 Dec 28;49(51):10831-41. (PMID: 21050007)
J Bacteriol. 1951 Dec;62(6):691-709. (PMID: 14907621)
J Am Chem Soc. 2009 Apr 1;131(12):4186-7. (PMID: 19275153)
J Am Chem Soc. 2008 Sep 17;130(37):12299-309. (PMID: 18712870)
Proc Natl Acad Sci U S A. 1978 Aug;75(8):3998-4000. (PMID: 279015)
Acta Vitaminol Enzymol. 1975;29(1-6):17-20. (PMID: 1244087)
J Biomol Screen. 2001 Dec;6(6):429-40. (PMID: 11788061)
J Med Chem. 2020 Apr 9;63(7):3552-3562. (PMID: 32073266)
Nat Commun. 2017 Nov 22;8(1):1693. (PMID: 29167421)
J Biol Chem. 1967 Nov 25;242(22):5260-6. (PMID: 6065097)
J Am Chem Soc. 2010 Sep 1;132(34):11993-2005. (PMID: 20698527)
Chem Rev. 1996 Nov 7;96(7):2841-2888. (PMID: 11848843)
Proc Natl Acad Sci U S A. 1979 Aug;76(8):4084-6. (PMID: 291064)
Adv Enzymol Relat Areas Mol Biol. 1969;32:55-96. (PMID: 4978050)
J Am Chem Soc. 2010 Apr 21;132(15):5494-500. (PMID: 20353179)
Arch Biochem Biophys. 1991 Dec;291(2):326-33. (PMID: 1952947)
Bioorg Med Chem Lett. 2011 May 1;21(9):2697-701. (PMID: 21194936)
J Am Chem Soc. 2003 Sep 10;125(36):10926-40. (PMID: 12952474)
Immunology. 2002 Dec;107(4):452-60. (PMID: 12460190)
J Immunother Cancer. 2018 Jun 20;6(1):61. (PMID: 29921320)
Tetrahedron. 1967 Jun;23(6):2855-61. (PMID: 6047529)
J Exp Med. 2002 Aug 19;196(4):459-68. (PMID: 12186838)
Org Lett. 2016 Mar 18;18(6):1470-3. (PMID: 26958741)
J Biol Chem. 2002 May 3;277(18):15788-94. (PMID: 11867636)
J Am Chem Soc. 2011 Oct 12;133(40):16251-7. (PMID: 21892828)
Proc Natl Acad Sci U S A. 2009 Oct 13;106(41):17371-6. (PMID: 19805032)
J Org Chem. 2006 Apr 28;71(9):3527-32. (PMID: 16626136)
Cancer Res. 2012 Nov 1;72(21):5435-40. (PMID: 23090118)
Oncotarget. 2014 Sep 30;5(18):8136-46. (PMID: 25327557)
Eur J Cancer. 2017 May;76:167-182. (PMID: 28324751)
FEBS J. 2012 Dec;279(24):4501-9. (PMID: 23083473)
J Med Chem. 2015 Dec 24;58(24):9421-37. (PMID: 25970480)
Cancer Res. 2007 Aug 1;67(15):7082-7. (PMID: 17671174)
J Exp Med. 1999 May 3;189(9):1363-72. (PMID: 10224276)
Oncotarget. 2016 Jun 21;7(25):37762-37772. (PMID: 27192116)
Biochem Soc Trans. 2008 Dec;36(Pt 6):1120-3. (PMID: 19021508)
Expert Opin Ther Pat. 2018 Apr;28(4):317-330. (PMID: 29473428)
Cancer Res. 2017 Dec 15;77(24):6795-6811. (PMID: 29247038)
J Biol Chem. 1974 Feb 25;249(4):1311-3. (PMID: 4814344)
J Biol Inorg Chem. 2017 Apr;22(2-3):175-183. (PMID: 27909919)
Biochemistry. 2008 Oct 7;47(40):10677-84. (PMID: 18783250)
J Mol Evol. 2007 Dec;65(6):705-14. (PMID: 18026683)
FEBS J. 2015 Aug;282(16):3190-8. (PMID: 25755053)
Nat Med. 2003 Oct;9(10):1269-74. (PMID: 14502282)
تواريخ الأحداث: Date Created: 20220103 Latest Revision: 20220104
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC8637876
DOI: 10.1039/d0cb00209g
PMID: 34977580
قاعدة البيانات: MEDLINE
الوصف
تدمد:2633-0679
DOI:10.1039/d0cb00209g